Milestone Scientific Inc. provided revenue guidance for the fourth quarter and year ended December 31, 2021. The Company anticipates revenue of over $2.6 million for the fourth quarter of 2021 compared to $2.2 million for the fourth quarter of 2020 and revenue in excess of $10 million for the fiscal year 2021 compared to revenue of $5.4 million for fiscal 2020.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.67 USD | 0.00% |
|
-6.94% | -2.88% |
06-18 | Milestone Scientific Says CompuFlo Epidural System Gains Approval in Brazil | MT |
06-18 | Milestone Scientific Receives Regulatory Approval to Market Compuflo Epidural System in Brazil | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.88% | 51.74M | |
+6.37% | 213B | |
+10.21% | 184B | |
+28.22% | 153B | |
+34.42% | 113B | |
+0.80% | 63.66B | |
+19.21% | 53.53B | |
+0.13% | 49.11B | |
-4.16% | 38.73B | |
+2.39% | 36.26B |
- Stock Market
- Equities
- MLSS Stock
- News Milestone Scientific Inc.
- Milestone Scientific Inc. Provides Revenue Guidance for the Fourth Quarter and Year Ended December 31, 2021